Related Experiment Video
Updated: Apr 22, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Pyruvylation: a link bridging metabolic disorders and impaired antiviral immunity
Song Yang1, Lili Gong1, Lihong Liu1
1China-Japan Friendship Hospital, Beijing 100029, China.
Abstract:
Zuo et al. identified a novel post-translational modification-protein pyruvylation-and revealed that pyruvate, a glycolysis metabolite, induces STAT1 pyruvylation at Lys201, which blocks signal transducer and activator of transcription 1 (STAT1)-signal transducer and activator of transcription 2 (STAT2) binding to suppress type I interferon signaling and antiviral immunity. This study provides new insights into antiviral therapy for patients with metabolic diseases.
Related Concept Videos
Biosynthesis of Nucleic Acids
Inhibitors of Viral Protein Synthesis
Inborn Errors of Metabolism
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Viruses with RNA Genomes
Retroviruses

